Passa al contenuto
Merck

GC-EI-MS analysis of fatty acid composition in brain and serum of twitcher mouse.

Lipids (2014-09-12)
Assunta Zanfini, Elena Dreassi, Anna Berardi, Paola Piomboni, Elvira Costantino-Ceccarini, Alice Luddi
ABSTRACT

Globoid cell leukodystrophy or Krabbe disease is an inherited autosomal recessive disorder caused by mutations in the galactosylceramidase gene. The objective of the study was to present information about the fatty acid (FA) composition of the brain and serum of twitcher mice, a mouse model of Krabbe disease, compared to wild type, in order to identify biomarker of disease progression. We defined the FA profiles by identifying the main components present in serum and brain using GC-EI-MS analysis. The FA percentage composition was measured and data were analyzed considering the disease and the mouse age as experimental factors. Significant correlations were established, both in brain and in serum, in the fatty acid percentage composition of twitcher compared to wild type mice. The most abundant saturated fatty acid in brain was the palmitic acid (C16:0) with mean values significantly increased in twitcher mouse (p = 0.0142); moreover, three monounsaturated, three polyunsaturated (PUFA) and a plasmalogen were significantly correlated to disease. In the serum highly significant differences were observed between the two groups for three polyunsaturated fatty acids. In fact, the docosahexaenoic acid (C22:6n3c) content was significantly increased (p = 0.0116), while the C20 PUFA (C20:3n6c and C20:5n3c) were significantly decreased in twitcher serum samples. Our study shows a specific FA profile that may help to define a possible pattern that could distinguish between twitcher and wild type; these data are likely to provide insight in the identification of new biomarkers to monitor the disease progression and thereby permit the critical analysis of therapeutic approaches.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Acido oleico, technical grade, 90%
Sigma-Aldrich
Palmitic acid, ≥99%
Sigma-Aldrich
Acido linoleico, ≥99%
Sigma-Aldrich
Linolenic acid, ≥99%
Sigma-Aldrich
Stearic acid, Grade I, ≥98.5% (capillary GC)
Sigma-Aldrich
Acido oleico, BioReagent, suitable for cell culture
Sigma-Aldrich
Acido linoleico, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
Acido oleico, ≥99% (GC)
Sigma-Aldrich
Palmitoleic acid, ≥98.5% (GC), liquid
Sigma-Aldrich
Palmitic acid, BioXtra, ≥99%
Sigma-Aldrich
Acido oleico, meets analytical specification of Ph, Eur., 65.0-88.0% (GC)
Sigma-Aldrich
Arachidonic acid, >95.0% (GC)
Sigma-Aldrich
Acido oleico, natural, FCC
Sigma-Aldrich
Myristic acid, Sigma Grade, ≥99%
Sigma-Aldrich
Arachidonic acid, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
Stearic acid, reagent grade, 95%
Sigma-Aldrich
Stearic acid, ≥95%, FCC, FG
Sigma-Aldrich
Acido linoleico, technical, 58-74% (GC)
Sigma-Aldrich
Lignoceric acid, ≥99% (GC)
Sigma-Aldrich
Palmitic acid, ≥98%, FCC, FG
Sigma-Aldrich
Nonanoic acid, ≥97%
Supelco
Stearic acid, analytical standard
Supelco
Acido oleico, analytical standard
USP
Stearic acid, United States Pharmacopeia (USP) Reference Standard
USP
Palmitic acid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Palmitic acid, ≥98% palmitic acid basis (GC)
Sigma-Aldrich
Nonanoic acid, ≥96%, FG
Sigma-Aldrich
Myristic acid, ≥95%, FCC, FG
Supelco
Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material